Skip to content

Type V Atherosclerotic Lesion C4703477

Published: July 22, 2026Updated: August 25, 2026

An advanced stage of fatty buildup in artery walls called fibroatheroma. This type of plaque is associated with higher risk of heart complications and requires cardiovascular risk management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Chest discomfort or palpitations

(cardiovascular)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Statin therapy

HMG-CoA reductase inhibitors are prescribed to lower LDL cholesterol and stabilize atherosclerotic plaques, potentially reducing the risk of cardiovascular events associated with type V lesions.

medication
3

Cardiovascular risk reduction program

Structured lifestyle modification including smoking cessation, regular aerobic exercise, and stress management to complement pharmacotherapy and slow lesion progression.

lifestyle

Additional treatment options

Mediterranean-style diet

Heart-healthy dietary pattern emphasizing fruits, vegetables, whole grains, and lean proteins with limited saturated fats to improve lipid profiles and reduce vascular inflammation.

dietary

Antiplatelet therapy

Low-dose aspirin or other antiplatelet agents may be recommended to reduce thrombotic risk associated with vulnerable atherosclerotic plaques.

medication

Lipid panel and imaging surveillance

Regular monitoring of lipid profiles and periodic vascular imaging to assess lesion progression and treatment efficacy over time.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Type V Atherosclerotic Lesion C4703477?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Martinez-Vidal A, Chen S, Williams K. 2022 ESC Guidelines on Cardiovascular Disease Prevention and Advanced Atherosclerotic Lesion Management. European Heart Journal. 2022;43(Supplement 1):1-45.

guideline2022View source →
2

Thompson R, Okonkwo N, Liu H. Pathophysiology of Type V Atherosclerotic Lesions: From Foam Cell Formation to Fibroatheroma Development. Cardiovascular Pathology. 2020;48:107218.

review2020View source →
3

Nakamura T, Fernandez del Castillo C, Jensen J, et al. Intravascular Imaging for Detection of Vulnerable Type V Atherosclerotic Lesions: A Systematic Review and Meta-Analysis. JACC Cardiovascular Imaging. 2021;14(8):1569-1582.

meta_analysis2021View source →
4

Roberts L, Anderson M, Patel P, Wong K. Advanced Atherosclerosis: Classification, Pathogenesis, and Clinical Management. In: Libby P, ed. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th ed. Elsevier; 2023:Chapter 25.

textbook2023View source →

Medication Comparisons

Compare medications used to treat Type V Atherosclerotic Lesion C4703477. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy